C07D 401/06
Linked by a carbon chain containing only aliphatic carbon atoms
Official title: linked by a carbon chain containing only aliphatic carbon atoms
C07D401/06 (Linked by a carbon chain containing only aliphatic carbon atoms) appears on 5,768 US grants and 6,045 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,768
- Published applications
- 6,045
- Assignees
- 1,882
- Inventors
- 16,714
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 11 | 0 |
| 1978 | 10 | 0 |
| 1979 | 6 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 9 | 0 |
| 1983 | 7 | 0 |
| 1984 | 14 | 0 |
| 1985 | 29 | 0 |
| 1986 | 33 | 0 |
| 1987 | 45 | 0 |
| 1988 | 43 | 0 |
| 1989 | 58 | 0 |
| 1990 | 69 | 0 |
| 1991 | 76 | 0 |
| 1992 | 63 | 0 |
| 1993 | 76 | 0 |
| 1994 | 68 | 0 |
| 1995 | 105 | 0 |
| 1996 | 105 | 0 |
| 1997 | 165 | 0 |
| 1998 | 128 | 0 |
| 1999 | 136 | 0 |
| 2000 | 126 | 0 |
| 2001 | 143 | 38 |
| 2002 | 164 | 163 |
| 2003 | 155 | 234 |
| 2004 | 130 | 316 |
| 2005 | 132 | 304 |
| 2006 | 127 | 279 |
| 2007 | 163 | 247 |
| 2008 | 157 | 247 |
| 2009 | 162 | 277 |
| 2010 | 184 | 324 |
| 2011 | 189 | 249 |
| 2012 | 209 | 226 |
| 2013 | 234 | 228 |
| 2014 | 247 | 275 |
| 2015 | 210 | 288 |
| 2016 | 201 | 265 |
| 2017 | 252 | 229 |
| 2018 | 186 | 233 |
| 2019 | 237 | 287 |
| 2020 | 189 | 233 |
| 2021 | 148 | 193 |
| 2022 | 102 | 193 |
| 2023 | 113 | 214 |
| 2024 | 113 | 194 |
| 2025 | 122 | 178 |
| 2026 | 91 | 131 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- D-amphetamine compounds, compositions, and processes for making and using the same15 Sep 2026US 12,735,388 B2Zevra Therapeutics, Inc.
- 2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(5-(phenyl)-pyridin-3-yl)methanone derivatives and similar compounds as CYP11A1 inhibitors for the treatment of prostate cancer15 Sep 2026US 12,735,408 B2Orion Corporation
- Bicyclic compound and use thereof25 Aug 2026US 12,715,866 B2SK Biopharmaceuticals Co., Ltd.
- Salt of piperidylindole compound and preparation method therefor1 Oct 2026US 2026/0297055 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Compounds for treating cancer1 Oct 2026US 2026/0297066 A1Genesis Molecular AI, Inc.
- Tetrahydroisoquinoline compounds as nrf2 activators1 Oct 2026US 2026/0297076 A1C4X Discovery Limited
- Substituted pyridine derivatives as sarm1 inhibitors24 Sep 2026US 2026/0285834 A1Nura Bio, Inc.
- Inhibitor of complement factor b24 Sep 2026US 2026/0285845 A1Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Trifunctional intermediates for preparing 3'-tailed oligonucleotides292US 5,512,667 A1996
- Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity220US 5,089,509 AAllergan, Inc. · 1992
- Inhibitors of farnesyl-protein transferase204US 5,856,326 AMerck & Co., Inc. · 1999
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990